The Latin America, Middle East and Africa Anastomosis Devices Market is expected to witness market growth of 9.9% CAGR during the forecast period (2022-2028).
In developed nations, the development of technologically improved technologies and advantageous reimbursement circumstances in cardiac procedures such as open-heart valve replacement, Coronary Bypass Graft Surgery, and angioplasty are boosting the Market for anastomosis devices. For example, Medicare Part B covers procedures such as coronary artery bypass graft surgery, valve repair and replacement, coronary angioplasty, and various cardiac rehabilitation programs.
Anastomotic devices are ideal for addressing such requirements. They allow the coronary surgeon to improve their technique without sacrificing quality. They can reduce the risk of perioperative neurological damage by eliminating inter- and intra-surgeon variability in technical competency and ensuring the quick construction of reproducible, reliable, and compliant anastomoses, typically in difficult-to-access locations. A broad majority of anastomotic devices released into the Market in the last two decades are no longer in use.
According to the national Library of Medicines, cardiovascular disease is one of the leading causes of death in this region as well, however, the epidemiology of CVD in UAE nationals is unknown. The risk of significant CVD was linked to a low estimated glomerular filtration rate, high systolic blood pressure, and poorly controlled diabetes in high-risk UAE nationals who did not have a history of CVD. Smoking and high TC-to-HDL-C ratios, particularly in women, are controllable risk factors that should be proactively handled.
According to the World Health Organization, the global burden of chronic diseases is quickly increasing, with the Eastern Mediterranean Region experiencing the highest growth in cardiovascular disease. In addition, the UAE has one of the world's highest age-standardized mortality rates for cardiovascular disease, with males dying at 308.9 per 100,000 and females dying at 203.9 per 100,000.
The Brazil Market dominated the LAMEA Anastomosis Devices Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $86.6 million by 2028. The Argentina Market is poised to grow at a CAGR of 10.5% during (2022-2028). Additionally, The UAE Market is expected to display a CAGR of 9.6% during (2022-2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By Country
In developed nations, the development of technologically improved technologies and advantageous reimbursement circumstances in cardiac procedures such as open-heart valve replacement, Coronary Bypass Graft Surgery, and angioplasty are boosting the Market for anastomosis devices. For example, Medicare Part B covers procedures such as coronary artery bypass graft surgery, valve repair and replacement, coronary angioplasty, and various cardiac rehabilitation programs.
Anastomotic devices are ideal for addressing such requirements. They allow the coronary surgeon to improve their technique without sacrificing quality. They can reduce the risk of perioperative neurological damage by eliminating inter- and intra-surgeon variability in technical competency and ensuring the quick construction of reproducible, reliable, and compliant anastomoses, typically in difficult-to-access locations. A broad majority of anastomotic devices released into the Market in the last two decades are no longer in use.
According to the national Library of Medicines, cardiovascular disease is one of the leading causes of death in this region as well, however, the epidemiology of CVD in UAE nationals is unknown. The risk of significant CVD was linked to a low estimated glomerular filtration rate, high systolic blood pressure, and poorly controlled diabetes in high-risk UAE nationals who did not have a history of CVD. Smoking and high TC-to-HDL-C ratios, particularly in women, are controllable risk factors that should be proactively handled.
According to the World Health Organization, the global burden of chronic diseases is quickly increasing, with the Eastern Mediterranean Region experiencing the highest growth in cardiovascular disease. In addition, the UAE has one of the world's highest age-standardized mortality rates for cardiovascular disease, with males dying at 308.9 per 100,000 and females dying at 203.9 per 100,000.
The Brazil Market dominated the LAMEA Anastomosis Devices Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $86.6 million by 2028. The Argentina Market is poised to grow at a CAGR of 10.5% during (2022-2028). Additionally, The UAE Market is expected to display a CAGR of 9.6% during (2022-2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Disposable and
- Reusable
- Cardiovascular Surgery
- Gastrointestinal Surgery and
- Others
- Hospitals and
- Ambulatory Care Centers & Clinics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- LivaNova PLC
- Becton, Dickinson and Company
- Johnson & Johnson
- Peters Surgical
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- ConMed Corporation
- Baxter International, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Anastomosis Devices Market by Product Type
Chapter 4. LAMEA Anastomosis Devices Market by Application
Chapter 5. LAMEA Anastomosis Devices Market by End User
Chapter 6. LAMEA Anastomosis Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Medtronic PLC
- LivaNova PLC
- Becton, Dickinson and Company
- Johnson & Johnson
- Peters Surgical
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- ConMed Corporation
- Baxter International, Inc.
Methodology
LOADING...
